HomePress-release
Redding, California - November 11, 2024

Tissue Engineering Market to reach $7.41 Billion by 2031

Tissue Engineering Market Size, Share, Forecast, & Trends Analysis by Product (Scaffold [Collagen, PLA, Stem Cells], Tissue Grafts [Allograft, Xenografts, Autografts]) Application (Musculoskeletal, Oncology, Cardiology) End User – Global Forecast to 2031


Meticulous Research®—a leading global market research company, published a research report titled Tissue Engineering Market - Global Opportunity Analysis and Industry Forecast (2024-2031)’. According to this latest publication, the tissue engineering market is expected to reach $7.41 billion by 2031, at a CAGR of 18.6% from 2024 to 2031.

This market is experiencing growth driven by the increasing approval rates for tissue engineering products, growing demand for regenerative medicine, expanded funding opportunities for the development of tissue engineering innovations, and a rising prevalence of musculoskeletal disorders. However, high treatment costs and ethical issues associated with the use of stem cells are hindering market growth.

In addition, advancements in tissue engineering products, the use of tissue engineering products in sports medicine, and the increasing application of tissue engineering products in newer therapy areas are providing potential growth opportunities for the market. However, unfavorable reimbursement policies and complexity in manufacturing are major challenges impacting market growth.

Key Players:

Some of the key players operating in global tissue engineering market report are Smith & Nephew plc (U.K.), Integra LifeSciences Holdings Corporation (U.S.), AbbVie Inc. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), Organogenesis Inc. (U.S.), Becton, Dickinson and Company (C. R. Bard) (U.S.), Baxter International Inc. (U.S.), Octane Medical Group (Canada), Tissue Regenix Group plc (U.K.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.).

The tissue engineering market is segmented by Product, Application, and End User.

Among the products studied in this report, the scaffold segment is anticipated to dominate the tissue engineering market in 2024. The growing demand for scaffolds in regenerative solutions, orthopedic, and wound healing applications is the key factor driving the largest market share in this segment. Additionally, innovations in scaffold materials, including 3D bioprinting, smart scaffolds, and biomimetic substances, are further reinforcing the segment's dominant position.

Among the applications studied in this report, the musculoskeletal & orthopedics segment is anticipated to dominate the tissue engineering market in 2024. Musculoskeletal disorders, which result from occupational injuries and age-related degeneration, are driving the largest share of this market segment. The growing incidence of musculoskeletal and orthopedic injuries is a key contributor to this trend. For example, the World Health Organization (WHO) reported that, in 2021, approximately 1.71 billion people worldwide were affected by musculoskeletal conditions. The WHO has projected a continued rise in the prevalence of disabilities related to these conditions in the coming decades. As of July 2022, this number included individuals who have osteoporosis, osteoarthritis, osteopenia, fragility fractures, and other related ailments. Tissue engineering products play a crucial role in alleviating pain and accelerating the healing process for orthopedic conditions. The benefits of these products in orthopedics are expected to drive continued market growth.

Among the end users studied in this report, the hospital & clinics segment is anticipated to dominate the tissue engineering market in 2024. Hospitals & clinics are the primary destinations for patients seeking diagnoses and treatments for a wide range of conditions. With a well-developed infrastructure, highly skilled healthcare professionals, and access to advanced treatment options, including various therapies, hospitals & clinics offer a comprehensive and accessible care environment. As a result, patients are increasingly choosing these facilities, contributing to their dominant share in the market segment.

Among the geographies studied in this report, North America is anticipated to dominate the tissue engineering market in 2024. The large share of this regional market is attributed to the rising prevalence of chronic conditions such as cancer and cardiovascular diseases, increasing funding for the development of tissue engineering, the presence of key market players in the region, and the rising number of clinical trials in the region.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6089

Key questions answered in the report-

  • Which are the high-growth market segments in terms of product, application, end user, and region/country?
  • What was the historical market size of the tissue engineering market globally?
  • What are the market forecasts and estimates for the period 2024–2031?
  • What are the major drivers, restraints, challenges, opportunities, and trends in the tissue engineering market?
  • Who are the major players in the tissue engineering market?
  • What is the competitive landscape like, and who are the market leaders in the reg tissue engineering market?
  • What are the recent developments in the tissue engineering market?
  • What are the different strategies adopted by the major players in the tissue engineering market?
  • What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Recommended Readings

  Download Free Sample
Table Of Content
Download Free Sample Report